TURKEL CATHERINE C.

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 46% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
TURKEL CATHERINE C.'s trades of Lexaria Bioscience Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
421.92
Quantity 22,186 -13.9%
Value US$285,021
Transaction date
Purchase
Price
244.95
Quantity 71,805 -33.3%
Value US$1,294,190
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-13 2024-08-12
B Purchase
22,186 -13.9%
421.92
US$285,021 		22,186 -13.9% 421.92 US$285,021
2023-02-27 2023-02-09
B Purchase
71,805 -33.3%
244.95
US$1,294,190 		71,805 -33.3% 244.95 US$1,294,190
2019-05-22 2019-05-21
S Sale
93,154 +10.4%
354.97
US$1,066,330 		93,154 +10.4% 354.97 US$1,066,330
2019-05-22 2019-05-20
S Sale
7,623 -7.8%
1.96
US$14,953 		7,623 -7.8% 1.96 US$14,953